All active patients enrolled in the HNHD program at the Humber River Regional Hospital (HRRH) in Toronto  2002 by the International Society of Nephrology were eligible, except those on the modality for less than Number of treatments three months during the study period. Selection criteria Methods were available to track the number of dialysis for this program required that the patient show a capacity treatments provided to each patient during the study for self-care training, functional literacy in English, and period. SMH tracks membrane usage at the patient level a life expectancy of more than one year. In addition, the as part of a dialyzer reuse program. HRRH has contracts patient was required to have sufficient manual, visual with private companies, which provide data for each treatand auditory abilities unless a spouse or other family ment on a patient-by-patient basis. A 5% random sample member could assist during treatments.
of treatment counts was audited against alternate sources Selection criteria for the control hospital required that (run sheets, HNHD monitoring logs) to assess accuracy. the hospital be university affiliated, located in the greater Censoring of data Toronto area, have an in-center hemodialysis program of sufficient size, and not have a home hemodialysis proAs this was an on-treatment analysis, it was expected that patients would have uneven durations of follow-up gram in operation. Based on these criteria, the control due to either late entry (following modality training or group was formed from patients attending the hemodialprogram transfer) or early exit from their initial modality ysis clinic at St. Michael's Hospital in Toronto (SMH).
(due to death, transplantation, or change of modality Control patients were selected based on suitability for type). To allow for variable follow-up, costs were exhome dialysis. The SMH program medical director, who pressed as the weekly cost of health care for each patient. was uninvolved with this study, was asked to screen all Patient data were collected only while the patients were SMH hemodialysis patients and identify those approon their initial modality, and a mean weekly cost was priate for home hemodialysis. Those selected were concalculated only for the time on-treatment. sidered eligible if they expressed an interest in home hemodialysis after description of the modality, and might Direct hemodialysis materials costs consider switching from center-based hemodialysis. As Direct hemodialysis materials expenses consisted of new patients entered both programs during the study all consumables for hemodialysis, including the dialysis period, they were screened for eligibility and approached membrane, medications delivered for dialysis (for examregarding enrollment.
ple, heparin), and additives to the dialysate (potassium Signed consents approved by local and university ethchloride, calcium chloride, and fleet phosphasoda), as ics review boards were obtained from all study subjects.
well as costs of monitoring treatments. As SMH has a dialyzer reuse program, a programmatic Costing methods analysis was performed to calculate the average cost of Prospective costing data were collected from January 1, reprocessing a membrane as well as the cost of purchasing 2000 to March 1, 2001 . The primary analysis involved a fresh membrane. For each patient, the number of fresh calculation of a weekly total cost of health-care as viewed and reprocessed membranes used through the study pefrom the perspective of the health-care provider. Costs riod was used to calculate their total membrane cost. were expressed in year 2000 Canadian dollars. An onAccess-specific connectivity costs including cannulae treatment analysis was used, and opportunity costs were for grafts and fistulae, and catheter caps for in-dwelling excluded. We assumed that either dialysis modality was lines were calculated. available to a patient, and so did not include an analysis A portion of the HNHD group was remotely moniof start-up costs or construction of new facilities. Capital tored during their treatments by either dedicated phone costs were amortized over seven years, reflecting the line or the Internet. These costs were included for those expected modality survival. patients who were monitored during the study period. For cost items that were calculated on a per-treatments
As not every item applied to each patient, an individubasis, the weekly cost was determined by multiplying alized per-treatment cost was determined accounting for each patient's per-treatment cost by their weekly average type of access, monitoring status, and hospital-specific number of treatments.
items. This calculation accounted for change of access Because programs typically have annual rather than type and monitoring status through the study period. weekly budgets, a projected annual cost was calculated Staffing for each patient by multiplying their weekly cost by 52.14.
Secondary analyses included a program-specific cost Salary and benefits for staff directly involved in the including only the cost of direct hemodialysis materials, provision of dialysis care were determined through destaffing, overhead and support, and depreciation, and a tailed hospital records. This included nursing staff, assisunit-specific cost that examined only direct hemodialysis tants, technical personnel, and other professionals (such as, pharmacists, social workers and dieticians). Managematerials, staffing and overhead, and support costs. rate analysis: anemia therapy (including erythropoietin and iron preparations), antibiotics, and cardiovascular medications (including antihypertensives, anti-anginals and therapies for ventricular dysfunction). ment personnel were included to the level of the unit manager, as were non-medical personnel such as secreAdmissions and procedures taries and administrative assistants.
Each in-patient admission was identified for all paTo further examine the differences in staffing costs, tients. Each hospital had existing methods for tracking an analysis of staffing complements for the two programs in-patient direct and indirect costs at a patient level. Outwas performed. The mean number of full-time equivapatient interventional procedures were identified also lents (FTE) for each staff category during the study pefor each patient, with costs based on the government riod was determined weekly on a per-patient basis.
Schedule of Benefits, which included fees for physicians, facilities, staffing and expendables.
Overhead and support

Overhead and support consisted of costs for support
Laboratory tests and medical imaging services including housekeeping, dictation, laundry, en-
The performance of laboratory and imaging studies gineering, and porters. Also included were costs for adwere tracked through a periodic review of the test results ministrative personnel above the level of unit manager, section of the patient chart, as well as each hospital's the costs of consumables unrelated to the direct provision laboratory database. The cost of radiology tests was deof dialysis (for example, office supplies), and utilities. At termined from the government Schedule of Benefits, SMH these costs are assigned through a single charge including both physician and technical fees. The cost of as a percentage of the dialysis program annual budget.
lab tests was based on charges by a private lab company At HRRH, a series of calculations were performed to that provided the bulk of out-patient lab services. Inallocate these costs to the HNHD program (Table 1) .
hospital test costs were based on fees charged at one hospital (SMH). Medications For each patient a drug profile was generated that Physician fees tracked medication use on a daily basis. All oral, parenThe Ontario government Physician Schedule of Beneteral and over-the-counter medications were included fits was used to determine the cost of physician services except those listed as a direct hemodialysis materials cost for the provision of dialysis care and for other services or those delivered during an in-patient admission (which such as consultations and follow-up visits. were captured as an Admission and Procedure cost). The Depreciation/capital costs physician order section, pharmacist notes, and computerbased pharmacy records were reviewed periodically. By All forms of hemodialysis incur capital expenses for determining the start and discontinuation dates of all equipment. The cost for acquisition of dialysis machines medications, a daily drug profile was generated for each and water treatment equipment was determined. The patient for every day of the study period. Drugs taken HNHD program required additional one-time items only as needed were assigned an estimated number taken such as the initial setup of all equipment in the home per day based on a patient interview.
and enuresis sensors used to detect blood leaks. A series of methods were used to assign a cost to As all patients performing HNHD must be trained each medication. The Ontario Ministry of Health Drug to perform the modality, the cost of training also was Benefit Formulary specifies the cost that the Ontario considered a depreciable expense. The average cost of government has agreed to pay for most medications.
training was determined by review of HRRH records, For those not listed, hospital formularies and program and included staffing time as well as consumables used purchase contracts were used to determine a drug's cost.
through the training period. For medications not listed in these sources, the drug Capital items were categorized as either reusable (that is, able to be used for a new patient if the current patient acquisition cost for a major international pharmacy chain study. The single session Kt/V for the HNHD group was Reusable items were amortized over seven years, while 1.59 Ϯ 0.22, and was 1.36 Ϯ 0.17 for the IHD group. non-reusable items were amortized over five years. A Weekly Kt/V was 9.1 for the HNHD group, and 4.1 for sensitivity analysis was performed to test the effect of the IHD group. shorter amortization periods. Table 3 summarizes the weekly and projected annual Demographic variables were analyzed as means (such costs for each modality. The overall cost of health care as age) and proportion (such as sex) as appropriate. Cost delivery for HNHD was 20% lower than for IHD variables were examined through comparison of weekly ($1,082 Ϯ $155 vs. $1,322 Ϯ $348, P ϭ 0.006). The promean values. Distribution shape and normality was jected annual cost for all categories was more than checked for all variables using normal and detrended $10,000 less with HNHD than IHD ($56,394 vs. $68,935). normal Q-Q plots and the Kolmogorov-Smirnov test When the scope was restricted to program-and fundingwith Lilliefor's significance correction. Normally distribspecific costs HNHD remained the less expensive option uted means were compared using the Student t test, (Table 4 ). All but five of the IHD patients had mean while variables failing normality testing were examined total annual costs higher than the mean total annual cost using the Mann-Whitney U test. Chi-squared tests were of the HNHD group. used for categorical variables. A significance level of 0.05
Total costs Statistics
Home nocturnal hemodialysis achieved this cost savwas used for all tests.
ing through reductions in several categories. Staffing costs were half that of IHD, and overhead and support RESULTS costs were reduced by two-thirds. There was a trend toward fewer days admitted to hospital for the HNHD Patient population group (1.8 vs. 6.8 admit-days/patient-year, P ϭ 0.13), A total of 38 patients participated in the HNHD proresulting in a total cost for admissions and procedures gram during the study period. Five were on the modality that was 15% of the IHD cost (P ϭ NS). There was also for less than three months during the study period. All a trend suggesting 25% lower medication expenses in remaining 33 patients agreed to participate.
the HNHD group (P ϭ 0.08). One hundred and eighty-two patients from the IHD These cost reductions made up for categories where program were screened, and 29 were considered eligible HNHD was more expensive. Costs for direct hemodialyfor home hemodialysis. Of these 29, three refused to sis materials were more than two times higher than IHD. consider home dialysis and three declined to participate Depreciable items were more than seven times more in the study, leaving 23 control patients. Over 2/3 of the expensive for HNHD. The costs of outpatient labwork IHD patients were performing in-center self-care hemotrended toward being 25% higher for the HNHD group dialysis. The HNHD and IHD groups had similar demo-(P ϭ 0.094). The mean HNHD training cost in 2000 was graphic features (Table 2) .
$10,201 per patient trained. By the end of the study period, 30 HNHD patients were still on the modality, with three patients having Direct hemodialysis materials costs received a transplant during the study period. Of the 23
The cost of 73 items required for the performance of IHD patients, one died and two were transplanted by the end of the study period.
hemodialysis was tracked. These items ranged in price (Table 6 ). The number of nursing staff per patient was from $0.01 to $11.00. The average cost per treatment for these items was about a quarter higher with HNHD than about 3/4 less for HNHD. The staff for both hospitals shared the same unions IHD ($56.16 Ϯ $3.55 vs. $41.64 Ϯ $5.08, P Ͻ 0.001). The cost to remotely monitor a patient via Internet for all for nursing, technical and support staff, leading to a shared pay scale for the majority of the employees. treatments over a one-year period was $3,096.
Staffing
Medications Table 7 outlines the differences seen in the pre-speciThe number of patients and staffing levels changed across the study period for both programs. in other areas such as hospital admissions. As programs b Non-reusable items include patient training, sensors, tourniquets, and home specific equipment mature, and the penetration of HNHD increases, it is likely that the reductions in non-modality expenses will improve.
Although we calculated the cost of depreciable equipPhysician fees ment and training, we did not calculate the cost of new In Ontario, physicians providing dialysis care receive facilities or start-up costs, which could be substantial in a weekly modality-independent fee for all medical sera new program. For these reasons, new HNHD programs vices, leading to an identical weekly cost of $127.55 per may not fully realize the overall cost savings described patient (projected mean annual cost of $6650). Outside here in the initial phases. Potential savings will also of nephrologic care, there were few physician encounters change as the patient mix shifts away from the healthiest in both groups that did not lead either to an admission individuals. Additional research will be needed as the or an intervention. Although attempts were made to use of HNHD spreads, and as existing programs grow. track these remaining physician encounters, charting and In addition to studying the cost of HNHD, we atpatient recall of these events was found to be unreliable.
tempted to compare the costs to those seen in a similar The mean number of identified encounters was small group of individuals who were performing in-center heand similarly judged too unreliable for analysis.
modialysis. To minimize the selection bias inherent in a non-randomized design, we selected a hospital where Sensitivity analysis there were patients eligible for home hemodialysis, but As depreciable expenses were significantly different where a home hemodialysis program did not exist. Our between the groups, and a long amortization period was selection process produced groups that were demographchosen for the primary analysis, a sensitivity analysis was ically similar, with a trend toward more congestive heart undertaken to determine the impact of shorter amortizafailure at baseline in the HNHD group (HNHD was used tion periods on the total weekly and projected annual as "rescue" therapy for some individuals with frequent costs. HNHD remained the less costly option in all sceexacerbations of heart failure). While the two groups narios. When a seven-year period is selected for reusable were similar, neither group is similar to the "average" items, the cost difference is statistically significant only hemodialysis patient. The individuals in this study tended if the patient remains on the modality for more than two to be younger, were unlikely to have diabetes, and had been on dialysis for a prolonged period. Our conclusions, years. If the reusable amortization period is reduced to therefore, should not be generalized to the broader dialfive years, a patient must stay on HNHD for more than ysis population. Although this study did not address the three years before statistical significance is reached (Taquestion of who is capable of performing home nocturnal ble 8).
hemodialysis, our selection process identified less than 16% of the patients from the SMH dialysis unit as being DISCUSSION potentially eligible. While there are many estimates of the cost of convenWhile selection bias was minimized by the selection tional hemodialysis, there exists no prospective patientof our control hospital and patients, this bias can only level estimate of the cost of home nocturnal hemodialybe fully avoided through the performance of a largesis. Our first goal was to produce an estimate of the scale prospective trial, with randomization of patients to cost of this new modality. To our knowledge, this study their form of dialysis. While methodological requirements led to the selecexamined the world's first and largest home nocturnal tion of the Humber River Regional Hospital and St.
